In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2.
Mulgaonkar N, Wang H, Mallawarachchi S, Ruzek D, Martina B, Fernando S
J Biomol Struct Dyn. 2022 Feb 26:1-10. doi: 10.1080/07391102.2022.2045221.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.